Aimei Health Technology Co., Ltd. (AFJK) EBITDA (2024 - 2025)
Aimei Health Technology's (AFJK) quarterly EBITDA came in at -$130152.0 in Q3 2025, up 34.93% year-over-year from -$96458.8 in Q3 2024, and down 212.84% quarter-over-quarter from -$41604.0 in Q2 2025.
Powered by 
Analysis
Aimei Health Technology Co., Ltd. (AFJK) EBITDA (2024 - 2025) Analysis & Trends
Aimei Health Technology (AFJK) has reported EBITDA for 2 consecutive years, with -$130152.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, EBITDA rose 34.93% year-over-year to -$130152.0 in Q3 2025; TTM through Sep 2025 was -$987191.0, a N/A change from a year earlier, with the FY2024 full-year figure at -$1.1 million, down 3641.47% from the prior year.
- EBITDA was -$130152.0 for Q3 2025 at Aimei Health Technology, down from -$41604.0 in the prior quarter.
- Over five years, EBITDA peaked at -$41604.0 in Q2 2025 and troughed at -$413414.0 in Q1 2025.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -130,152.00 |
| Jun 30, 2025 | -41,604.00 |
| Mar 31, 2025 | -413,414.00 |
| Dec 31, 2024 | -402,021.00 |
| Sep 30, 2024 | -200,019.00 |
| Jun 30, 2024 | -309,114.00 |
| Mar 31, 2024 | -153,632.00 |